- Curida has partnered with Rommelag to install Europe’s first BFS bottelpack 550 line at its facility in Norway.
- The partnership enhances Curida’s CDMO capabilities in nasal spray, ophthalmic, and aseptic fill-finish manufacturing.
Curida, a European Contract Development and Manufacturing Organization (CDMO), has announced a strategic partnership with Rommelag to install Europe’s first BFS bottelpack 550 line at its Norwegian manufacturing site.
The collaboration represents an investment in advancing fill-finish technology, reinforcing Curida’s role in providing nasal spray, ophthalmic, and other aseptic and non-aseptic manufacturing solutions. The BFS 550 line is expected to enhance flexibility, innovation, and sustainability within Curida’s contract manufacturing operations.
Curida stated that this collaboration with Rommelag “strengthens our position as a leading European CDMO for Nasal Spray, Ophthalmics and other aseptic and non-aseptic fill finish solutions — delivering innovation, flexibility, and sustainability for our clients & partners worldwide.”
